Intercellular communication is a critical process that ensures cooperation between distinct cell types and maintains homeostasis. EVs, which were initially described as cellular debris and devoid of biological function, are now recognized as key components in cell–cell communication. EVs are known to carry multiple factors derived from their cell of origin, including cytokines and chemokines, active enzymes, metabolites, nucleic acids, and surface molecules, that can alter the behavior of recipient cells. Since the cargo of EVs reflects their parental cells, EVs from damaged and dysfunctional tissue environments offer an abundance of information toward elucidating the molecular mechanisms of various diseases and pathological conditions. In this review, we discuss the most recent findings regarding the role of EVs in the progression of cancer, metabolic disorders, and inflammatory lung diseases given the high prevalence of these conditions worldwide and the important role that intercellular communication between immune, parenchymal, and stromal cells plays in the development of these pathological states. We also consider the clinical applications of EVs, including the possibilities for their use as novel therapeutics. [Figure not available: see fulltext.] [MediaObject not available: see fulltext.]
CITATION STYLE
Berumen Sánchez, G., Bunn, K. E., Pua, H. H., & Rafat, M. (2021, December 1). Extracellular vesicles: mediators of intercellular communication in tissue injury and disease. Cell Communication and Signaling. BioMed Central Ltd. https://doi.org/10.1186/s12964-021-00787-y
Mendeley helps you to discover research relevant for your work.